Analyst Ratings February 13, 2026

Citizens Lowers Upstart to Market Underperform, Assigns $20 Target

Valuation cited as primary concern after company issues three-year guidance; Q4 2025 shows EPS miss but revenue beat

By Hana Yamamoto UPST
Citizens Lowers Upstart to Market Underperform, Assigns $20 Target
UPST

Citizens has downgraded Upstart Holdings Inc. from Market Perform to Market Underperform and established a $20.00 price target. The research house says the move is largely valuation-driven following the release of three-year medium-term guidance, and it highlights both marketwide pressure on fintech lenders with private credit exposure and mixed fourth-quarter 2025 results from the company.

Key Points

  • Citizens downgraded Upstart from Market Perform to Market Underperform and set a $20.00 price target.
  • The downgrade is largely valuation-based following the release of three-year medium-term guidance; the stock has fallen 23% since reporting fourth-quarter results and remains below its 52-week high.
  • Upstarts Q4 2025 results were mixed: EPS of $0.17 missed the $0.46 forecast (63.04% negative surprise), while revenue of $296 million beat expectations of $288.45 million (2.64% positive surprise).

Citizens has reduced its rating on Upstart Holdings Inc (NASDAQ:UPST) from Market Perform to Market Underperform and set a price target of $20.00.

The firm described the downgrade as primarily valuation-based, pointing to increased clarity around the companys earnings power after Upstart provided three-year medium-term guidance. Citizens said that, despite shares trading below their 52-week high and falling 23% since reporting fourth-quarter results earlier this week, the stock still appears expensive on current metrics.

Citizens also observed that Upstart has been swept up in a broader sell-off affecting financial technology lenders that carry private credit exposure. The firm concluded that the present valuation does not sufficiently capture comparable peer multiples or the potential risks to Upstarts outlook.

On the fundamentals disclosed in the companys recent financials, Upstart reported its fourth-quarter 2025 results with mixed outcomes. Earnings per share came in at $0.17, missing analyst expectations of $0.46 and representing a 63.04% negative surprise. Revenue, however, exceeded forecasts: the company posted $296 million compared with the anticipated $288.45 million, a 2.64% positive surprise. Citizens characterized its assessment of valuation against this backdrop as informing the downgrade.

The recent reports did not include specified analyst opinions or forward-looking expectations from other firms. Citizens private assessment centers on relative valuation and disclosed guidance, and the firm notably referenced market dynamics affecting the fintech lending peer group.

Investors and market participants will likely continue to focus on Upstarts upcoming earnings and revenue disclosures for further signals on the companys performance versus guidance. These developments are part of the recent financial disclosures from the company.


Contextual note - The downgrade from Citizens and the companys mixed fourth-quarter 2025 results together frame the near-term narrative for Upstart: valuation scrutiny on one side and top-line strength on the other. Market reactions have already pressured the stock, and further company updates will be watched closely.

Risks

  • Valuation risk - Citizens believes current share valuation does not adequately reflect peer multiples or the potential downside risks to Upstarts outlook, impacting investor return expectations.
  • Market contagion risk - Upstart has been affected by a broader sell-off in fintech lenders with private credit exposure, creating sector-level pressure on stocks in the space.
  • Earnings clarity risk - The sizeable EPS shortfall in Q4 2025 introduces uncertainty around near-term earnings power, even as revenue exceeded forecasts.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026